Clinical Trial Update: A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating the efficacy and safety of Baxdrostat in participants with primary hyperaldosteronism. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperaldosteronism

Drugs mentioned

• Baxdrostat (Baxdrostat)

Snippet

Sponsor: AstraZeneca | Conditions: Primary Hyperaldosteronism | Phase 3 | Status: RECRUITING